Compare IBIO & FIEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBIO | FIEE |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | 43 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4M | 15.6M |
| IPO Year | N/A | N/A |
| Metric | IBIO | FIEE |
|---|---|---|
| Price | $2.15 | $3.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 14.2M | N/A |
| Earning Date | 02-09-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 185.71 | N/A |
| 52 Week Low | $0.56 | N/A |
| 52 Week High | $6.89 | N/A |
| Indicator | IBIO | FIEE |
|---|---|---|
| Relative Strength Index (RSI) | 59.24 | 55.96 |
| Support Level | $1.82 | $2.51 |
| Resistance Level | $2.68 | $3.97 |
| Average True Range (ATR) | 0.24 | 0.26 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 44.39 | 43.19 |
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.